In contrast to the FTC-133 cell line, Nthy-ori 3–1 revealed a significant up-regulation of ERK1 and ERK2 in RPM AD cells but not in RPM MCS cells after 7 days. This evidence concerns the gene MAPK3 and Alzheimer disease.